Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients.
about
Immunotherapy in gastric cancerClinical application of adoptive T cell therapy in solid tumorsMultivariate statistical data analysis as a tool to analyze ex vivo expansion dynamics of cytokine-induced killer cells.Cytokine-induced killer cells co-cultured with dendritic cells loaded with the protein lysate produced by radiofrequency ablation induce a specific antitumor response.Conjugation of toll-like receptor-7 agonist to gastric cancer antigen MG7-Ag exerts antitumor effects.Efficacy of adjuvant chemotherapy combined with immunotherapy with cytokine-induced killer cells for gastric cancer after d2 gastrectomy.Cytokine-induced killer (CIK) cells: from basic research to clinical translation.A Positive Role of Cytokine-Induced Killer Cell Therapy on Gastric Cancer Therapy in a Chinese Population: A Systematic Meta-Analysis.Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine-induced killer cell therapy in hepatobiliary and pancreatic cancer.Immunotherapy for gastrointestinal malignancies.Cytokine-induced killer cells promote antitumor immunityCurative Effects of Dendritic Cells Combined with Cytokine-Induced Killer Cells in Patients with Malignant Pericardial Effusion.Clinical studies applying cytokine-induced killer cells for the treatment of gastrointestinal tumors.Cytokine induced killer cells as promising immunotherapy for solid tumors.New adoptive immunotherapy strategies for solid tumours with CIK cells.Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectives.Cancer Immunotherapy with Cytokine-Induced Killer Cells.The emerging role of immunotherapy in gastric and esophageal adenocarcinoma.The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?Efficacy of adoptive cellular therapy in patients with gastric cancer: a meta-analysis.Effect of cytokine-induced killer cells on immune function in patients with lung cancer.A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocellular carcinoma.Clinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature reviewAutologous cytokine-induced killer cell immunotherapy may improve overall survival in advanced malignant melanoma patients.Immunotherapy for Gastric Cancer: Time for a Personalized Approach?Immunotherapy in Melanoma, Gastrointestinal (GI), and Pulmonary MalignanciesPrognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancerCytokine-induced killer cell/dendritic cell-cytokine-induced killer cell immunotherapy for the postoperative treatment of gastric cancer: A systematic review and meta-analysis
P2860
Q27010472-4E87D4DC-FF68-4B00-BFF3-8B0C64730275Q27011283-057EB11E-6F3C-4D68-A628-BB532F8DD232Q30664844-BDEC8D2E-74A0-44EF-8AD7-EDF13D8FE235Q35167582-A050E430-DEAC-4C00-8BF3-7D26A4AF631DQ35843039-D74AA793-F359-4B27-964D-8C40AB7C8709Q35870886-53AE8FF2-0F00-4B11-AB4A-AD2B3A858AEEQ36121153-FCAA6630-B0C2-46CD-A2E7-8FFB8FE653EBQ36263711-046DE58F-86A4-416D-AE80-16D452C6B065Q36502870-C698B096-B89C-475D-9BBA-CFAE7092192CQ36602174-9650F553-1288-460F-88EE-AEA20B40592DQ36741617-825703BD-C4E4-47D9-99AC-DA0A9BD1E46FQ37395436-BB8F2AD2-B5E1-46CE-8ACA-D669043AF163Q37704879-96E3A204-7F2B-4ECF-B5D2-4BD03A2C612AQ37895924-3AF386F3-8858-4CA4-BD4A-B790D460F500Q37996561-303FABA3-89E6-4547-A044-7C48B30A3102Q38002494-A178CC30-36DC-401C-B717-2921B09C529AQ38574526-F0125363-B9A0-4098-88D5-D2D5D8F13BA8Q38687547-5EF9F175-4A84-4909-BB51-EEA26311EEE8Q38831655-524FA9DD-C3BF-4E2A-8BA7-DFBEC47892A4Q38835601-4A94907C-7A1C-4BC0-AE84-E8B5BD1D8ED5Q38887317-66212247-AA7D-4494-BAAB-A6519F0DAB0EQ39651813-3E1AF992-01C3-46BF-B53C-3B5159581280Q40224948-40BCEE4F-E3F6-43E4-996A-521F62A46913Q42283208-3491B07D-E82B-4592-8997-DAB1CFD1A8CAQ47733182-E7F25FE4-7EBF-48DA-90AA-5098D89F705EQ55652343-575B7EA5-FFA1-4301-AAF6-6425BC166986Q56896166-FE3EF830-B0DF-43AB-AB0A-4953E328634DQ57167306-4F0D3B64-C183-4900-B2FB-AE59FB81A996Q58759294-B71DCB63-E0A8-46BD-B058-724BD93ACA13
P2860
Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Increasing the frequency of CI ...... th in gastric cancer patients.
@ast
Increasing the frequency of CI ...... th in gastric cancer patients.
@en
Increasing the frequency of CI ...... th in gastric cancer patients.
@nl
type
label
Increasing the frequency of CI ...... th in gastric cancer patients.
@ast
Increasing the frequency of CI ...... th in gastric cancer patients.
@en
Increasing the frequency of CI ...... th in gastric cancer patients.
@nl
prefLabel
Increasing the frequency of CI ...... th in gastric cancer patients.
@ast
Increasing the frequency of CI ...... th in gastric cancer patients.
@en
Increasing the frequency of CI ...... th in gastric cancer patients.
@nl
P2093
P2860
P356
P1476
Increasing the frequency of CI ...... th in gastric cancer patients.
@en
P2093
Bin-Feng Lu
Chang-Ping Wu
Jing-Ting Jiang
Lu-Jun Chen
Wen-Xiang Wei
Xiao Zheng
Xue-Guang Zhang
Yi-Bei Zhu
Yue-Ping Shen
P2860
P304
P356
10.3748/WJG.V16.I48.6155
P407
P577
2010-12-01T00:00:00Z